SRPT News and Press, Sarepta Therapeutics Inc. From 05/01/24

2024-05-01 19:30:13 ET Image source: The Motley Fool. Sarepta Therapeutics (NASDAQ: SRPT) Q1 2024 Earnings Call May 01, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: Sarepta Therapeutics (SRPT) Q1 2024 Earnings Call Tr...

2024-05-01 17:22:07 ET Sarepta Therapeutics, Inc. (SRPT) Q1 2024 Earnings Conference Call May 01, 2024 04:30 PM ET Company Participants Mary Jenkins - Associate Director, Investor Relations & Corporate Communications Douglas Ingram - President & Chief Executi...

2024-05-01 16:56:58 ET More on Sarepta Therapeutics Sarepta Therapeutics: Growth Trajectory Alters Trading Strategy Sarepta Therapeutics: Another 'Hold' Call Ahead Of Some Key Catalysts Sarepta Therapeutics, Inc. (SRPT) Q4 2023 Earnings Call Transcript Sarept...

2024-05-01 16:10:48 ET More on Sarepta Therapeutics Sarepta Therapeutics: Growth Trajectory Alters Trading Strategy Sarepta Therapeutics: Another 'Hold' Call Ahead Of Some Key Catalysts Sarepta Therapeutics, Inc. (SRPT) Q4 2023 Earnings Call Transcript Sarept...

Net product revenues for the first quarter 2024 totaled $359.5 million, a 55% increase over the same quarter of the prior year ELEVIDYS net revenues for the quarter totaled $133.9 million Achieved GAAP Earnings of $36.1 million for the first quarter 2024 and non-GA...

2024-05-01 09:15:00 ET A lot will change in the next 10 years, but our need for innovative medicines is unlikely to be one of them. That's one thing that makes some biotech companies exciting long-term investment opportunities, at least highly innovative ones that look well-positioned to de...

2024-04-30 17:20:38 ET More on Sarepta Therapeutics Sarepta Therapeutics: Growth Trajectory Alters Trading Strategy Sarepta Therapeutics: Another 'Hold' Call Ahead Of Some Key Catalysts Sarepta Therapeutics, Inc. (SRPT) Q4 2023 Earnings Call Transcript As mor...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report first quarter 2024 financial results after the Nasdaq Global Market closes on Wednesday, May 1, 2024. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discu...

2024-04-23 10:29:06 ET More on Edgewise Therapeutics Edgewise Therapeutics: Behind The Massive Rally Krystal Biotech, Candel, Edgewise gain after FDA fast track tags Seeking Alpha’s Quant Rating on Edgewise Therapeutics Historical earnings data for Edg...

2024-04-16 12:22:50 ET More on rare disease pharmas/biotechs Sarepta Therapeutics: Growth Trajectory Alters Trading Strategy Sarepta Therapeutics: Another 'Hold' Call Ahead Of Some Key Catalysts Ultragenyx Pharmaceutical Earnings: No Visible Path To Financial Success...